Found 534 hits.
| 217 | Netchiporouk, E., Nguyen, C. H., Thuraisingham, T., Jafarian, F., Maurer, M. and Ben-Shoshan, M.+: Management of pediatric chronic spontaneous and physical urticaria patients with Omalizumab: case series. Pediatr. Allergy Immunol. 2015: 26; 585-588. IF: 3.94 |
| 398. | Tawil, S.+, Irani, C., Kfoury, R., Salameh, P., Baiardini, I., Weller, K., Maurer, M., and Ezzedine, K.: The Arabic urticaria activity score and chronic urticaria quality of life questionnaire: validation and correlations. Int. J. Dermatol. 2020: 59; 893-901. IF: 2.74 |
o.398
| 229 | Metz, M., Weller, K., Neumeister, C., Izquierdo, I., Bödeker, R. H., Schwantes, U.+, and Maurer, M.:Rupatadine in established treatment schemes improves chronic spontaneous urticaria symptoms and patients’ quality of life: a prospective, non-interventional trial. Dermatol. Ther. 2015: 5; 217-230. IF: 1.26 |
| 154 | Kolkhir, P., Altrichter, S., Muñoz, M., Hawro, T., and Maurer, M.+: New treatments for chronic urticaria. Ann. Allergy Asthma Immunol. 2020: 124; 2-12. IF: 6.35 |
r.154
| 101. | Mitchell, S., Balp, M. M., Samuel, M., McBride, D., and Maurer, M.: Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments. Int. J. Dermatol. 2015: 54; 1088-1104. IF: 1.41 |
r.101
| 372 | Kolkhir, P., Church, M. K., Altrichter, S., Stahl Skov, P., Hawro, T., Frischbutter, S., Metz, M., and Maurer, M.+: Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity and poor response to treatment. J. Allergy Clin. Immunol. Pract. 2020: 8; 318-325. IF: 8.86 |
o.372
| 108 | Franzke, N.+, Schäfer, I., Jost, K., Blome, C., Rustenbach, S. J., Reich, K., Reusch, M., Maurer, M. and Augustin, M.: A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis. Allergy 2011: 66; 665-670. IF: 6.27 |
| 278 | Caballero, T. + Aberer, W., Longhurst, H. J., Maurer, M. Zanichelli, A., Perrin, A., Bouillet, L., and Andresen, I.: The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries. J. Eur. Acad. Dermatol. Venereol. 2017: 31; 1214-1222. IF: 4.29 |
| 188 | Kay, A. B.+, Ying, S., Ardelean, E., MÅ‚ynek, A., Kita, H., Clark, P., and Maurer, M.: Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria. Clin. Exp. Allergy 2014: 44; 1053-1060. IF: 4.77 |
| 276 | Tabeling, C., Herbert, J., Hocke, A. C., Lamb, D., Wollin, L., Erb, K., Boiarina, E., Movassagh, H., Scheffel, J., Doehn, J. M., Hippenstiel, S., Maurer, M. Gounni, A., S., Kuebler, W. M., Suttorp, N., and Witzenrath, M.: Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2-induced airway inflammation and remodeling. Allergy 2017: 72; 1061-1072. IF: 6.05 |